B. Konatkowska

Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study

J. Wachowiak, M. Piątkowska, T. Szczepański, 2013, Leukemia & lymphoma.

Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.

T. Szczepański, W. Badowska, J. Styczyński, 2010, Anticancer research.

Chronic Disseminated Candidiasis Complicated by Immune Reconstitution Inflammatory Syndrome in Child with Acute Lymphoblastic Leukemia

J. Wachowiak, K. Jończyk-Potoczna, O. Zając‐Spychała, 2016, Case reports in hematology.

In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.

J. Wachowiak, T. Szczepański, W. Badowska, 2005, Neoplasma.

Clinical, immunophenotypic and genetic characteristics of infant acute lymphoblastic leukemia

J. Wachowiak, T. Szczepański, K. Muszyńska-Rosłan, 2013 .

Infant acute bilineal leukemia.

J. Wachowiak, R. Marschalek, C. Meyer, 2009, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Juvenile xanthogranuloma with clonal proliferation in the bone marrow.

E. Mały, J. Nowak, D. Januszkiewicz, 2012, Journal of pediatric hematology/oncology.

Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.

J. Wachowiak, T. Szczepański, W. Badowska, 2008, Anticancer research.

International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.

E. Mejstrikova, O. Hrusak, M. Schrappe, 2018, Blood.